Core Viewpoint - The company plans to propose the cancellation of its supervisory board and amend its current articles of association in response to the revised Company Law of the People's Republic of China, which will take effect on July 1, 2024 [1] Group 1: Legislative Changes - The revised Company Law introduces reforms including changes to the capital system and organizational structure, enhanced protection for minority shareholders, and increased responsibilities for controlling shareholders, directors, and senior management [1] - The China Securities Regulatory Commission issued important documents on March 28, 2025, to ensure compliance with the new regulations [1] Group 2: Proposed Amendments - The board of directors suggests several amendments to the current articles of association, including the cancellation of the supervisory board and the establishment of an audit committee to perform its functions [1] - The proposed changes aim to strengthen the protection of shareholder rights and make necessary adjustments in accordance with applicable laws and regulations [1] - Additional internal affairs and miscellaneous changes are also included in the proposed amendments [1]
劲方医药-B(02595.HK)建议取消监事会及修订组织章程细则